Tags Posts tagged with "NYCBS"

NYCBS

New York Cancer & Blood Specialists (NYCBS), one of the nation’s leading oncology practices, is proud to announce the addition of Jin Guo, MD. She will practice at 1500 Rt 112, Bldg 4, Port Jefferson Station.

“We are proud to welcome Dr. Jin Guo to the NYCBS team,” said Jeff Vacirca, MD, CEO of NYCBS. “We are confident that Dr. Guo’s expertise and compassionate approach will greatly benefit our patients and further enhance our mission to provide exceptional cancer care.”

Dr. Guo’s love for oncology’s scientific and humanistic aspects led her to medicine. “It’s important to understand what makes cancer cells grow and what we can do to fight cancer but building a human connection is equally important,” Dr.Guo said. “I became an oncologist because it requires expertise in both. Oncology is an art and a science.”

After supporting her grandmother through her cancer journey, Dr. Guo pursued the field to deliver the highest quality cancer care to her patients while supporting their families and caregivers. “My philosophy is to not only treat the person behind the cancer but also to encourage and empower my patients to be active participants in their own care through communication, trust, and respect.” Dr. Guo said.

Dr. Guo received her Doctor of Medicine from the University at Buffalo School of Medicine and Biomedical Sciences. She completed her Hematology/Oncology Fellowship with a Master Clinician Track at The University of Texas MD Anderson Cancer Center, renowned for its exceptional cancer care and groundbreaking research. Prior to her fellowship, Dr. Guo served as an Internal Medicine Resident at New York Presbyterian-Weill Cornell Medicine.

To make an appointment with Dr. Guo, please call 631-751-3000. For more information, visit nycancer.com.

Dr. Neal Murphy. Photo courtesy of NYCBS

New York Cancer & Blood Specialists (NYCBS) recently announced the addition of oncologist-hematologist Neal Murphy, MD. 

Dr. Murphy will practice at 750 Old Country Rd, Riverhead,640 County Rd, Southampton, and 49 Route 347, Port Jefferson Station.

“Dr. Murphy’s dedication to research and patient care is truly commendable,” said Jeff Vacirca, MD, CEO of NYCBS. “We are proud to have Dr. Murphy join our practice and look forward to the positive impact he will make in the lives of our patients.”

Dr. Murphy has dedicated his time to research focusing on kidney and bladder cancer. Dr. Murphy completed two translational research studies, including “Prognostic molecular signatures for metastatic potential in clinically low-risk stage I and II clear cell renal cell carcinomas,” which was published in Frontiers in Oncology, and “Predictive molecular biomarkers for determining neoadjuvant chemosensitivity in muscle-invasive bladder cancer” which was published in Oncotarget. 

Dr. Murphy has several other peer-reviewed publications and has presented his work at national conferences. He remains passionate about optimizing treatments in hematology/oncology and treats a broad spectrum of diseases with a focus on genitourinary, lung, head and neck, colorectal and skin malignancies, as well as multiple myeloma and lymphoma.

“I strive to get to know all my patients, build trust and provide the kind of care that one of my family members or I would want to receive,” Dr. Murphy said. 

“When communicating with patients, I am honest and open, explaining all treatment options and agreeing on the best, personalized treatment plan together. It is rewarding to be able to alleviate a patient’s anxiety and fear about their diagnosis and to be able to provide hope because there are so many effective treatments NYCBS and I can offer to help patients.”

To make an appointment with Dr. Murphy, please call 631-751-3000. For more information, visit nycancer.com.

New York Cancer & Blood Specialists (NYCBS) has announced the appointments of Paul Kazemier to Senior Vice President of Patient Communications and Kathryn Paliotta to Vice President of Patient Communications.

“Paul’s appointment as Senior Vice President of Patient Communications is a testament to his exceptional leadership in overseeing a team of over 275+ employees and his continued dedication to enhancing patient communication,” said Jeff Vacirca, MD, CEO of NYCBS. “His forward-thinking approach and adaptability to change will enable the organization to achieve improved outcomes for healthcare providers and patients, demonstrating our commitment to delivering exceptional value to our partners, patients, and the community.”

“Kathryn’s dedication and leadership have been invaluable to our organization, and we are thrilled to recognize her contributions with this well-deserved promotion,” said Vacirca. “Her extensive clinical background, coupled with her ability to effectively manage our patient communication departments, has allowed us to provide even better care and support to our patients. We look forward to seeing her continued success in her new role as Vice President of Patient Communications.”

“I am incredibly grateful for this promotion and the opportunity to continue to lead and grow my departments. It means the world to me,” said Kazemier. “My goal is to not only ensure the highest level of patient satisfaction and experience but also to foster an environment where employees can grow within the company and achieve their own success.”

“I am immensely grateful to have found my niche,” Paliotta said. “Working for an organization as diverse as ours has afforded me the privilege to care for patients across various specialties. I have also had the pleasure to learn from an inspiring group of mentors and look forward to growing my career at NYCBS.”

For more information, visit nycancer.com.

Anthony Peterson

New York Cancer & Blood Specialists (NYCBS), has announced the appointment of Anthony Peterson to Chief of Business Development.

“Anthony’s promotion to Chief is a significant step in our ongoing efforts to create an organization that provides exceptional value to our partners, patients, and the community,” said Jeff Vacirca, MD, CEO of NYCBS. “With his demonstrated ability to embrace change and think creatively, we are confident that he will be instrumental in leading the organization towards improved outcomes, benefiting healthcare providers and patients alike. I am excited to see the next stage of business growth for NYCBS under his leadership.”

Peterson previously served as Vice President in the development, management, and driving of strategic partnerships and key business opportunities. As Chief, he will continue to work closely under the direction of OneOncology’s Chief Development Officer, Jimmy Harper, and Vice President of Development, Henry Varnell, to cultivate and strengthen relationships and growth at a national level.

“I am thrilled and grateful to have been promoted to the role of Chief,” said Peterson. “This appointment is a testament to NYCBS’ unwavering commitment to fostering diversity and developing leadership talent. I am excited to align our business development efforts with our strategic direction and execution, and to contribute to the continued growth and success of the company.” 

For more information, please visit nycancer.com.